- Home
- EMF vs CATX Comparison
EMF vs CATX Comparison
Compare EMF & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMF
- CATX
- Stock Information
- Founded
- EMF 1987
- CATX 1983
- Country
- EMF United States
- CATX United States
- Employees
- EMF N/A
- CATX N/A
- Industry
- EMF Finance/Investors Services
- CATX Medical/Dental Instruments
- Sector
- EMF Finance
- CATX Health Care
- Exchange
- EMF Nasdaq
- CATX Nasdaq
- Market Cap
- EMF 254.5M
- CATX 239.0M
- IPO Year
- EMF N/A
- CATX N/A
- Fundamental
- Price
- EMF $16.55
- CATX $2.17
- Analyst Decision
- EMF
- CATX Strong Buy
- Analyst Count
- EMF 0
- CATX 11
- Target Price
- EMF N/A
- CATX $11.73
- AVG Volume (30 Days)
- EMF 29.3K
- CATX 2.0M
- Earning Date
- EMF 01-01-0001
- CATX 11-10-2025
- Dividend Yield
- EMF 6.16%
- CATX N/A
- EPS Growth
- EMF N/A
- CATX N/A
- EPS
- EMF N/A
- CATX N/A
- Revenue
- EMF N/A
- CATX $1,075,000.00
- Revenue This Year
- EMF N/A
- CATX N/A
- Revenue Next Year
- EMF N/A
- CATX N/A
- P/E Ratio
- EMF N/A
- CATX N/A
- Revenue Growth
- EMF N/A
- CATX N/A
- 52 Week Low
- EMF $10.58
- CATX $1.60
- 52 Week High
- EMF $12.67
- CATX $5.39
- Technical
- Relative Strength Index (RSI)
- EMF 36.07
- CATX 37.68
- Support Level
- EMF $16.12
- CATX $1.96
- Resistance Level
- EMF $16.95
- CATX $2.54
- Average True Range (ATR)
- EMF 0.27
- CATX 0.20
- MACD
- EMF -0.16
- CATX 0.03
- Stochastic Oscillator
- EMF 23.46
- CATX 42.74
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.